Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from thyroid C cells
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Background: Survival of medullary thyroid carcinoma (MTC) subgroups in relation to the
general population is poorly described. Data on the factors predicting long-term biochemical …

It has been proved that long noncoding RNAs (lncRNAs) are important modulators in the
tumorigenesis and progression of various malignant tumors. Recently, lncRNA FOXD2‐AS1 …

Background: Expression of the programmed death-ligand 1 (PD-L1) in medullary thyroid
carcinoma (MTC) has been rarely reported. In this study, we evaluated PD-L1 positivity in …

Background: Preoperative predictors for the need of prophylactic lymph node dissection in
the lateral neck have been studied in patients with medullary thyroid carcinoma (MTC) …

Background The improvement in outcome of sporadic medullary thyroid carcinoma (MTC)
during the last decades remains controversial, even if a trend toward a better prognosis has …

Lymph node (LN) metastases are widely considered as a vital assessment of disease
progression, as well as an essential indicator for biochemical cure of medullary thyroid …

Background: Medullary thyroid carcinoma (MTC) is rare. Nationwide population-based
studies are important to evaluate its clinical course. Objectives: To describe all patients with …

Background We aimed to investigate the prognostic role of examined (dissected) lymph
nodes (ELNs), negative LNs (NLNs), and positive (metastatic) LNs (PLNs) counts and LN …